TOLLIP and neoplasm: Genetic markers of T cells and B cells (CD3E and CD79A) were upregulated in the primary tumor, whereas M2 macrophage/microglia-related (CD163) and natural killer-cell-related (CD56) genes were upregulated in the BM, alongside anti-inflammatory markers, toll interacting protein (TOLLIP), and human leukocyte antigen G (HLA-G).